triphenyltetrazolium has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, SD; Hale, SL; Kay, GL; Kloner, RA; Simkhovich, BZ | 1 |
| Hara, H; Morimoto, N; Nagai, H; Shimazawa, M; Yamashima, T | 1 |
2 other study(ies) available for triphenyltetrazolium and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Do antioxidant vitamins reduce infarct size following acute myocardial ischemia/reperfusion?
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Chromans; Disease Models, Animal; Drug Therapy, Combination; Free Radical Scavengers; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Random Allocation; Staining and Labeling; Tetrazolium Salts; Vitamin E | 1995 |
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.
Topics: Animals; Antioxidants; Benzimidazoles; Benzoxazoles; Biphenyl Compounds; Brain Edema; Brain Infarction; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Chromans; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Fluorescent Dyes; Glutamic Acid; Hydrazines; Infarction, Middle Cerebral Artery; Inhibitory Concentration 50; Ischemia; Lipid Peroxidation; Male; Mice; Minocycline; Neurons; Neuroprotective Agents; Oxidative Stress; Picrates; Quinolinium Compounds; Saponins; Tetrazolium Salts; Time Factors | 2005 |